A tunable metabolic valve for precise growth control and increased product formation in Pseudomonas putida

被引:6
|
作者
Batianis, Christos [1 ]
van Rosmalen, Rik P. [1 ]
Major, Monika [1 ]
van Ee, Cheyenne [1 ]
Kasiotakis, Alexandros [1 ]
Weusthuis, Ruud A. [2 ]
dos Santos, Vitor A. P. Martins [1 ,2 ,3 ]
机构
[1] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands
[2] Wageningen Univ & Res, Bioproc Engn, Wageningen, Netherlands
[3] LifeGlimmer GmbH, Berlin, Germany
关键词
Growth control; Metabolic valve; Flux redirection; Pyruvate dehydrogenase; Pseudomonas putida; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; DYNAMIC CONTROL; L-LYSINE; PATHWAY; STRATEGIES; CONVERSION; PYRUVATE; GLUCOSE;
D O I
10.1016/j.ymben.2022.10.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Metabolic engineering of microorganisms aims to design strains capable of producing valuable compounds under relevant industrial conditions and in an economically competitive manner. From this perspective, and beyond the need for a catalyst, biomass is essentially a cost-intensive, abundant by-product of a microbial conversion. Yet, few broadly applicable strategies focus on the optimal balance between product and biomass formation. Here, we present a genetic control module that can be used to precisely modulate growth of the industrial bacterial chassis Pseudomonas putida KT2440. The strategy is based on the controllable expression of the key metabolic enzyme complex pyruvate dehydrogenase (PDH) which functions as a metabolic valve. By tuning the PDH activity, we accurately controlled biomass formation, resulting in six distinct growth rates with parallel overproduction of excess pyruvate. We deployed this strategy to identify optimal growth patterns that improved the production yield of 2-ketoisovalerate and lycopene by 2.5- and 1.38-fold, respectively. This ability to dynamically steer fluxes to balance growth and production substantially enhances the potential of this remarkable microbial chassis for a wide range of industrial applications.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 37 条
  • [31] A 9-pool metabolic structured kinetic model describing days to seconds dynamics of growth and product formation by Penicillium chrysogenum
    Tang, Wenjun
    Deshmukh, Amit T.
    Haringa, Cees
    Wang, Guan
    van Gulik, Walter
    van Winden, Wouter
    Reuss, Matthias
    Heijnen, Joseph J.
    Xia, Jianye
    Chu, Ju
    Noorman, Henk J.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (08) : 1733 - 1743
  • [32] METABOLIC AND ENERGETIC CONTROL OF PSEUDOMONAS-MENDOCINA GROWTH DURING TRANSITIONS FROM AEROBIC TO OXYGEN-LIMITED CONDITIONS IN CHEMOSTAT CULTURES
    VERDONI, N
    AON, MA
    LEBEAULT, JM
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1992, 58 (09) : 3150 - 3156
  • [33] The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
    Singh, Kailash
    Sandler, Stellan
    Espes, Daniel
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [34] Metabolic control and treatment of malignant growth:: tumor, regularities of amino acid imbalance formation and anti-cancer drug ''Ukrain''®
    Nefyodov, LI
    Doroshenko, YM
    Smirnov, VY
    Karavay, AV
    Nowicky, JW
    FEBS JOURNAL, 2005, 272 : 558 - 558
  • [35] Combined application of the biological product LS213 with Bacillus, Pseudomonas or Chryseobacterium for growth promotion and biological control of soil-borne diseases in pepper and tomato
    Domenech, J
    Reddy, MS
    Kloepper, JW
    Ramos, B
    Gutierrez-Mañero, J
    BIOCONTROL, 2006, 51 (02) : 245 - 258
  • [36] Combined Application of the Biological Product LS213 with Bacillus, Pseudomonas or Chryseobacterium for Growth Promotion and Biological Control of Soil-Borne Diseases in Pepper and Tomato
    J. Domenech
    M. S. Reddy
    J. W. Kloepper
    B. Ramos
    J. Gutierrez-Mañero
    BioControl, 2006, 51 : 245 - 258
  • [37] Effect of glucose levels in increased neutrophil extracellular trap formation (NETS) in type 2 diabetes patients at diagnosis and after 6 and 12 months of metabolic control
    Schattner, M. A.
    Carestia, A.
    Frechtel, G.
    Cerrone, G.
    Gonzalez, C.
    Linari, M. A.
    Casais, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 379 - 379